doi: 10.1111/cob.12203 [DOI] [PMC free article] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article.
So whos right
Gloss AD, Vasso DG, Hailey AL, Nelson Dittrich AC, Schramm K, Reichelt M
Monitoring and Follow-up Regular follow-ups for blood glucose and weight are significant for users who use semaglutide
Sodium Imbalance in Patients with Acquired HO and Central Diabetes Insipidus: Patients with acquired HO and concomitant central diabetes insipidus (DI)/arginine vasopressin (AVP) deficiency reported hyponatremia in 6% of IMCIVREE-treated patients and 2% of placebo-treated patients and hypernatremia in 5% of IMCIVREE-treated patients and 4% of placebo-treated patients
Karges B, Schwandt A, Heidtmann B, et al